Technical Analysis for ZSAN - Zosano Pharma Corporation

Grade Last Price % Change Price Change
grade B 4.83 -5.11% -0.26
ZSAN closed down 4.86 percent on Friday, March 22, 2019, on 26 percent of normal volume.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Very Strong Up Up Down
See historical ZSAN trend table...

Date Alert Name Type % Chg
Mar 22 Parabolic Rise Strength -5.11%
Mar 22 Inside Day Range Contraction -5.11%
Mar 22 Upper Bollinger Band Touch Strength -5.11%
Mar 21 Crossed Above 20 DMA Bullish -9.72%
Mar 21 Pocket Pivot Bullish Swing Setup -9.72%
Mar 21 Parabolic Rise Strength -9.72%
Mar 21 Upper Bollinger Band Touch Strength -9.72%
Mar 20 Fell Below 20 DMA Bearish 1.05%
Mar 20 Hammer Candlestick Bullish 1.05%
Mar 20 1,2,3 Pullback Bullish Bullish Swing Setup 1.05%

Older signals for ZSAN ...

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:
Profile
Zosano Pharma Corporation, a clinical stage specialty pharmaceutical company, develops drug formulations for the treatment of various indications. The company delivers formulations through the skin using its proprietary transdermal microneedle patch system. Its lead product candidates comprise Weekly ZP-PTH, a proprietary formulation of parathyroid hormone that has completed a Phase I clinical study for the treatment of severe osteoporosis in women; ZP-Glucagon, a proprietary formulation of glucagon, which has completed a Phase I study for the emergency treatment of severe hypoglycemia; and ZP-Triptan, a proprietary formulation of zolmitriptan that has completed preclinical animal studies for the treatment of migraine. Zosano Pharma Corporation has a strategic partnership and license agreement with Novo Nordisk A/S to develop a microneedle patch product to administer semaglutide for the treatment of type 2 diabetes. The company was founded in 2006 and is headquartered in Fremont, California.
Diabetes Migraine Stage Specialty Pharmaceutical Treatment Of Migraine Emergency Treatment Severe Hypoglycemia Triptans
Is ZSAN a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 4 bullish, 0 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 15.63
52 Week Low 1.85
Average Volume 2,625,649
200-Day Moving Average 3.7894
50-Day Moving Average 3.48
20-Day Moving Average 4.919
10-Day Moving Average 5.015
Average True Range 0.5893
ADX 52.31
+DI 36.3169
-DI 7.724
Chandelier Exit (Long, 3 ATRs ) 4.8821
Chandelier Exit (Short, 3 ATRs ) 4.2879
Upper Bollinger Band 5.3974
Lower Bollinger Band 4.4406
Percent B (%b) 0.68
BandWidth 19.451108
MACD Line 0.4304
MACD Signal Line 0.4921
MACD Histogram -0.0617
Fundamentals Value
Market Cap 199.66 Million
Num Shares 39.2 Million
EPS -1.28
Price-to-Earnings (P/E) Ratio -3.98
Price-to-Sales 0.00
Price-to-Book 1.29
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 5.65
Resistance 3 (R3) 5.69 5.54 5.55
Resistance 2 (R2) 5.54 5.40 5.52 5.52
Resistance 1 (R1) 5.32 5.31 5.25 5.28 5.49
Pivot Point 5.17 5.17 5.14 5.15 5.17
Support 1 (S1) 4.95 5.03 4.88 4.91 4.69
Support 2 (S2) 4.80 4.94 4.78 4.66
Support 3 (S3) 4.58 4.80 4.63
Support 4 (S4) 4.54